1-1 of 1
Maarten J. D. van Tol
Close
Sort by
Journal Articles

Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study

Clinical Trials & Observations
Federica R. Achini-Gutzwiller, Marco W. Schilham, Erik G. J. von Asmuth, Anja M. Jansen-Hoogendijk, Cornelia M. Jol-van der Zijde, Maarten J. D. van Tol, Robbert G. M. Bredius, Tayfun Güngör, Arjan C. Lankester, Dirk Jan A. R. Moes
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4462–4474.
https://doi.org/10.1182/bloodadvances.2022009051
Published: 2023
Includes: Supplemental data